CaV1.3 antagonist-1 Catalog No.:M17026-C Solubility: DMSO : ≥ 100

Solubility: DMSO : ≥ 100 mg/mL (250

Dopexamine reduces the systemic inflammatory response to endotoxin

Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells

the biologically active form of MLN9708

Na/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22

CaV1.3 antagonist-1 Catalog No.:M17026-C Solubility: DMSO : ≥ 100CaV1. 3 antagonist 1 is a potent and highly selective CaV1. 3 L type calcium channel (LTCC) antagonist with an IC50 of 1. 7 M. CaV1. 3 antagonist 1 inhibits CaV1. 3 LTCC >600 fold more potently than CaV1. 2 LTCC. CaV1. 3 antagonist 1, a cyclopentyl derivative, has the potential for Parkinson's disease research. Product information CAS Number: 1391385 57 1 Molecular Weight: 334. 80 Formula: C17H19ClN2O3 Chemical Name: 1 (3 chlorophenethyl) 3